Welldoc and Redox are teaming-up to allow providers to receive and review insights about users of Welldoc’s BlueStar digital health app for diabetes management directly within their EHR at the point of care. This, the two companies claim, will help optimize clinical decision support by making more patient data available in real time — which is critical for patients managing a chronic disease.
“To be successful, digital health solutions require frictionless data flow for the consumer and clinicians. We have done that for the consumer with integrations into their devices,” Welldoc Chief Strategy Officer Anand Iyer said in a statement. “Redox has taken an inside-out approach with the interoperability of EHRs, which is why we are excited to partner with them. Together, we are paving the way for the entire industry.”
BlueStar provides precise, AI-based real-time feedback focused on engaging patients to manage their health with clinical decision support. Welldoc’s digital health tools work with the Redox network to ensure products are capable and securely executing meaningful, bidirectional integration workflows with a vendor-agnostic platform for healthcare data exchange.
Today, more than 600 healthcare organizations using 45 EHR vendors trust Redox to strategically integrate digital health solutions into their day-to-day operations. Through this partnership, Welldoc’s BlueStar is immediately interoperable with any organization using Redox for healthcare data exchange to optimize the provider and patient experience.
“Welldoc is fundamentally changing the way patients live with diabetes and establishing a standard for the industry with a commitment to integrations with CGMs, wearables, and EHRs,” added Luke Bonney, co-founder and CEO of Redox. “We are excited and proud to be a part of Welldoc’s mission and to ensure that the actionable insights derived by the BlueStar platform are made available to providers in an optimal way.”
The digital transformation of healthcare will continue to gain momentum in 2020 based on growing interest from healthcare providers, pharma and insurance companies, and tech giants. Both Redox and Welldoc are working toward making digital health a driving force toward improving the health of those individuals living with chronic disease.